Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaixi Ren

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axisChao Zhang, Zonghao Pan, Xuli Ma, et al.
Frontiers in Immunology|December 3, 2021
Case Report: Prominent Brainstem Involvement in Two Patients With Anti-CASPR2 Antibody-Associated Autoimmune EncephalitisPei Liu, Miao Bai, Chao Ma, et al.
Journal of Autoimmunity|November 10, 2022
Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J/NR4A1 axisKaixi Ren, Sanzhong Li, Shiqian Liang, et al.
Heliyon|May 28, 2024
The ratio of circulating CD56<sup>dim</sup> NK cells to follicular T helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosisJiaqi Ding, Xu Yan, Cong Zhao, et al.
Journal of the American Heart Association|April 19, 2024
In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological StateKaixi Ren, Songwang Hou, Steven E Johnson, et al.
Frontiers in Immunology|August 24, 2023
Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up studyDaidi Zhao, Kaixi Ren, Jiarui Lu, et al.
Frontiers in Oncology|September 15, 2022
LncRNA GAS5 represses stemness and malignancy of gliomas <i>via</i> elevating the SPACA6-miR-125a/let-7e AxisShuang Wu, Kaixi Ren, Jing Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 25, 2023
Late-Onset Anti-GABA<sub>B</sub> Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset PatientsTangna Sun, Daidi Zhao, Gejuan Zhang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Immunology (Orlando, Fla.)|February 19, 2026
Polymorphonuclear myeloid-derived suppressor cells inhibit natural killer cell function in neuromyelitis optica spectrum disorder via the CD155-TIGIT axisChao Zhang, Zonghao Pan, Xuli Ma, et al.
Frontiers in Immunology|December 3, 2021
Case Report: Prominent Brainstem Involvement in Two Patients With Anti-CASPR2 Antibody-Associated Autoimmune EncephalitisPei Liu, Miao Bai, Chao Ma, et al.
Journal of Autoimmunity|November 10, 2022
Notch signaling dependent monocyte conversion alleviates immune-mediated neuropathies by regulating RBP-J/NR4A1 axisKaixi Ren, Sanzhong Li, Shiqian Liang, et al.
Heliyon|May 28, 2024
The ratio of circulating CD56<sup>dim</sup> NK cells to follicular T helper cells as a promising predictor for disease activity of relapsing-remitting multiple sclerosisJiaqi Ding, Xu Yan, Cong Zhao, et al.
Journal of the American Heart Association|April 19, 2024
In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological StateKaixi Ren, Songwang Hou, Steven E Johnson, et al.
Frontiers in Immunology|August 24, 2023
Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up studyDaidi Zhao, Kaixi Ren, Jiarui Lu, et al.
Frontiers in Oncology|September 15, 2022
LncRNA GAS5 represses stemness and malignancy of gliomas <i>via</i> elevating the SPACA6-miR-125a/let-7e AxisShuang Wu, Kaixi Ren, Jing Zhao, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 25, 2023
Late-Onset Anti-GABA<sub>B</sub> Receptor Encephalitis: Clinical Characteristics and Outcomes Differing From Early-Onset PatientsTangna Sun, Daidi Zhao, Gejuan Zhang, et al.
Pageof 2